Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastrointest Surg. Sep 27, 2025; 17(9): 109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980

Full Size Figure Download Figure

Figure 1 Study flow chart: 39 participants were enrolled and 24 were recruited. Each group includes 8 participants.

Citation: Qin X, Chen J, Zhang HN, Du L, Ma Y, Li Y, Lu Y, Wang YT, Wu LF, Yu ZH, Hu MJ, Li LJ, Liao B, Li Z, Yang ZY, Li K, Yuan YF. Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial. World J Gastrointest Surg 2025; 17(9): 109980
URL: https://www.wjgnet.com/1948-9366/full/v17/i9/109980.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.109980

Qin X, Chen J, Zhang HN, Du L, Ma Y, Li Y, Lu Y, Wang YT, Wu LF, Yu ZH, Hu MJ, Li LJ, Liao B, Li Z, Yang ZY, Li K, Yuan YF. Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial. World J Gastrointest Surg 2025; 17(9): 109980 [PMID: 41024792 DOI: 10.4240/wjgs.v17.i9.109980]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.